Trop2 deal heats up antibody–drug conjugate space in cancer

被引：0
|
作者：
Catherine Shaffer
机构：
来源：
Nature Biotechnology | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gilead’s $21 billion gamble is a dramatic shot to secure a promising first-in-class oncology drug.
引用
收藏
页码：128 / 130
页数：2
相关论文
共 50 条
  • [41] High expression of TROP2 correlates with poor prognosis in pancreatic cancer
    D Fong
    P Moser
    C Krammel
    J M Gostner
    R Margreiter
    M Mitterer
    G Gastl
    G Spizzo
    British Journal of Cancer, 2008, 99 : 1290 - 1295
  • [42] TROP2 is a novel, major determinant in breast cancer growth and metastatization
    Alberli, S.
    Trerolola, M.
    Vacca, G.
    Zappacosta, R.
    Rossi, C.
    Guerra, E.
    Bonasera, V
    Lasorda, R.
    Lattanzio, R.
    Piantelli, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S29 - S29
  • [43] TROP2 methylation and expression in tamoxifen-resistant breast cancer
    Zimmers, Stephanie M.
    Browne, Eva P.
    Williams, Kristin E.
    Jawale, Rahul M.
    Otis, Christopher N.
    Schneider, Sallie S.
    Arcaro, Kathleen F.
    CANCER CELL INTERNATIONAL, 2018, 18
  • [44] A literature review of the promising future of TROP2: a potential drug therapy target
    Wen, Ying
    Ouyang, Dengjie
    Zou, Qiongyan
    Chen, Qitong
    Luo, Na
    He, Hongye
    Anwar, Munawar
    Yi, Wenjun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (24)
  • [45] Case report: Prolonged benefit of ESG401, a Trop2 antibody-drug conjugate, in endocrine-refractory hormone receptor-positive, HER-2 negative metastatic breast cancer
    Zhao, Jing
    Huang, Fengbo
    Xu, Xia
    Zhang, Yan
    Xing, Xiaoyan
    Huang, Jian
    Qiu, Fuming
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [46] Overexpression of TROP2 promotes proliferation and invasion of ovarian cancer cells
    Wu, Bin
    Yu, Chunli
    Zhou, Bin
    Huang, Tingting
    Gao, Lei
    Liu, Tao
    Yang, Xingsheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (03) : 1947 - 1952
  • [47] Quantitative Measurement of TROP2 via Chromogenic Immunohistochemistry in Breast Cancer
    He, Mengni
    Liu, Matthew
    Aung, Thazin
    Burela, Sneha
    Bates, Katherine
    Robbins, Charles
    Rimm, David
    CANCER RESEARCH, 2024, 84 (09)
  • [48] ImmunoPET imaging of Trop2 for PSMA-Negative Prostate Cancer
    Long, X.
    Wei, W.
    Lan, X.
    Jiang, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S447 - S447
  • [49] TROP2 is a major determinant of growth and metastatic spreading of human cancer
    Alberti, S.
    Trerotola, M.
    Vacca, G.
    Zappacosta, R.
    Rossi, C.
    Guerra, E.
    Bonasera, V.
    Lasorda, R.
    Lattanzio, R.
    Piantelli, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] High expression of TROP2 correlates with poor prognosis in pancreatic cancer
    Fong, D.
    Moser, P.
    Krammel, C.
    Gostner, J. M.
    Margreiter, R.
    Mitterer, M.
    Gastl, G.
    Spizzo, G.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1290 - 1295
12345